Type II transmembrane serine protease gene variants associate with breast cancer.
Type II transmembrane serine proteases (TTSPs) are related to tumor growth, invasion, and metastasis in cancer. Genetic variants in these genes may alter their function, leading to cancer onset and progression, and affect patient outcome. Here, 464 breast cancer cases and 370 controls were genotyped...
Guardado en:
Autores principales: | Kaisa Luostari, Jaana M Hartikainen, Maria Tengström, Jorma J Palvimo, Vesa Kataja, Arto Mannermaa, Veli-Matti Kosma |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/60d8d1f823cd4bec995d3ad95a823deb |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Γ-secretase components as predictors of breast cancer outcome.
por: Hanna M Peltonen, et al.
Publicado: (2013) -
Interaction of protein C inhibitor with the type II transmembrane serine protease enteropeptidase.
por: Thomas A Prohaska, et al.
Publicado: (2012) -
Downregulation of serine protease HTRA1 is associated with poor survival in breast cancer.
por: Anna Lehner, et al.
Publicado: (2013) -
SARS-CoV-2 receptor ACE2 is co-expressed with genes related to transmembrane serine proteases, viral entry, immunity and cellular stress
por: Wasco Wruck, et al.
Publicado: (2020) -
The serine protease inhibitors and plant-insect interaction
por: Mendoza-Blanco,Werner, et al.
Publicado: (2012)